Stay Informed on Corporate Sustainability

Author: Archie Villaflores

Ireland-based biotech company Aerska has raised $39 million in Series A funding to advance brain shuttle technology for delivering RNA medicines across the blood-brain barrier for neurological diseases.

Author: Archie Villaflores

Malaysia-based Duopharma Biotech has secured a government contract valued at approximately RM65.08 million (€14.08 million) to supply recombinant human insulin formulations to the Ministry of Health.

Author: Archie Villaflores

Philippines-based BauerTek Pharmaceutical Technologies has signed a memorandum of agreement with Rizal Technological University for strategic collaboration in medicinal plant research and production.

Author: Archie Villaflores

Denmark-based Novo Nordisk plans to expand its Athlone facility in Ireland to manufacture weight loss drug Wegovy for non-US markets, chief executive Mike Doustdar has confirmed to Bloomberg.

Author: Archie Villaflores

Ireland-based Alkermes has completed its $2.3 billion acquisition of Avadel Pharmaceuticals, adding FDA-approved narcolepsy treatment LUMRYZ to its commercial portfolio and accelerating entry into the sleep medicine market.

Author: Archie Villaflores

Pharmaceutical innovation reflects AI integration and strategic partnership models that compress development timelines whilst expanding market access. Progress emerges where diagnostic technology, distribution infrastructure, and computational drug discovery converge to strengthen commercial outcomes and patient impact. Revisiting a standout moment from last year, 'Deciphex wins Innovation of the Year at Pharma Industry Awards 2025' celebrates how AI-powered pathology platforms deliver measurable clinical impact through diagnostic workflow optimisation. This recognition establishes expectations for the 2026 awards, where real-world patient outcomes and operational scale will distinguish winning healthcare technologies. In addition, 'Bioreve Sciences secures nationwide retail partnership with Uniphar Group' demonstrates how Irish manufacturers leverage distribution agreements to expand market reach. Strategic retail partnerships enable supplement producers to scale domestic presence whilst maintaining supply chain control. Meanwhile, 'Takeda partners with Iambic on $1.7 billion AI drug discovery programme' illustrates how pharmaceutical companies deploy AI-driven molecular design platforms to compress preclinical timelines and reduce development costs. Multi-billion dollar partnerships validate computational approaches that predict protein binding and accelerate compound optimisation. These stories underscore a sector where technological capability, commercial infrastructure, and partnership strategy determine competitive advantage. Explore each article to understand how technology and collaboration are reshaping pharmaceutical sector performance.

Author: Archie Villaflores

Awarded for pioneering AI-powered diagnostics in 2025, Deciphex won Innovation of the Year at the Pharma Industry Awards, setting new standards for intelligent healthcare as the 2026 awards cycle approaches.

Author: Archie Villaflores

South Korea-based Sky Labs has signed an exclusive distribution deal with Japan-based Otsuka Pharmaceutical to launch its ring-type blood pressure monitor CART BP pro in Japan. The device is prescribed in over 1,700 medical institutions in Korea.

Author: Archie Villaflores

Japan-based Takeda Pharmaceutical has signed a partnership worth over $1.7 billion (€1.44 billion) with US-based privately held Iambic to develop AI-designed small-molecule drugs. The agreement targets cancer and gastrointestinal diseases with milestone payments and royalties.

Author: Archie Villaflores

ArrayPatch has announced the first close of a €3 million seed funding round led by Lakeside Capital. The Cork company is advancing ITZ-DerMap, a novel treatment for onychomycosis using its proprietary polymer-free DerMap platform technology.